Medicine and HealthNATURE COMMUNICATIONS
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
D. Sun, Z. Sang, et al.
This study explores the transformative potential of nanobodies in neutralizing SARS-CoV-2 variants, revealing their resistance to variants of concern and the discovery of unique neutralizing epitopes. Conducted by a talented team of researchers from the University of Pittsburgh and beyond, the findings highlight nanobodies' advantages over traditional antibodies, paving the way for innovative pan-coronavirus vaccines and therapeutics.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
T. Li, W. Xue, et al.
Medicine and Health
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
M. C. Miranda, E. Kepl, et al.
Medicine and Health
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
H. Ma, Y. Guo, et al.
Medicine and Health
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
W. Chen, A. Hajduczki, et al.
